Comparison of Posterior and Anterior Approach to Sacrospinous Ligament Apical Fixation - Randomized Controlled Trial
Launched by HAEMEK MEDICAL CENTER, ISRAEL · Mar 10, 2020
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical methods for treating pelvic organ prolapse (POP) in women, specifically focusing on a type called apical prolapse, which can occur after a hysterectomy. The trial aims to compare the success rates of two approaches: one that accesses the area from the front (anterior) of the vagina and another that approaches it from the back (posterior). Researchers want to find out which method works better for women suffering from this condition.
To be eligible for the trial, women need to have a certain level of prolapse (grade 2 or higher) in both the apical area and the front wall of the vagina and must be experiencing symptoms that require surgery. The trial is currently looking for participants, and those who join can expect to undergo one of the two surgical methods while contributing to important research that could help improve treatment for pelvic organ prolapse in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with grade 2 or above apical prolapse, according to POP Q, combined with Grade II or above of anterior wall prolapse.
- • Women who suffer from symptomatic POP and care for a surgical treatment
- Exclusion Criteria:
- • Women with a contra-indication for surgical treatment
About Haemek Medical Center, Israel
Haemek Medical Center, located in Israel, is a leading healthcare institution renowned for its commitment to advancing medical research and patient care. With a strong emphasis on clinical trials, the center collaborates with multidisciplinary teams to explore innovative treatments and therapies across various medical fields. Haemek Medical Center is dedicated to maintaining high ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing valuable insights to the global medical community. Through its robust research programs and state-of-the-art facilities, the center aims to enhance healthcare outcomes and foster scientific advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Afula, , Israel
Patients applied
Trial Officials
meirav breverman, MD
Principal Investigator
haemek medical center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials